Patents by Inventor Ziad Kawar

Ziad Kawar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of treating sickle cell disease with anti-P-selectin antibodies
    Patent number: 9556266
    Abstract: The invention features antibodies, e.g., chimeric and humanized antibodies, that recognize (i.e., bind) P-selectin. The P-selectin antibodies prevent P-selectin from binding to its cognate receptor. The P-selectin antibodies can be used to treat inflammatory and thrombotic conditions, e.g., sickle cell disease, pain crisis associated with sickle cell disease, deep vein thrombosis, asthma, rheumatoid arthritis, psoriasis, and ischemia reperfusion injury in a patient in need thereof.
    Type: Grant
    Filed: February 1, 2013
    Date of Patent: January 31, 2017
    Assignees: Selexys Pharmaceuticals, Inc., Oklahoma Medical Research Foundation
    Inventors: Rodger P. McEver, Richard Alvarez, Ziad Kawar
  • Anti-P-Selectin Antibodies and Methods of Using The Same to Treat Inflammatory Diseases
    Publication number: 20140072551
    Abstract: The invention features antibodies, e.g., chimeric and humanized antibodies, that recognize (i.e., bind) P-selectin. The P-selectin antibodies prevent P-selectin from binding to its cognate receptor. The P-selectin antibodies can be used to treat inflammatory and thrombotic conditions, e.g., sickle cell disease, pain crisis associated with sickle cell disease, deep vein thrombosis, asthma, rheumatoid arthritis, psoriasis, and ischemia reperfusion injury in a patient in need thereof.
    Type: Application
    Filed: February 1, 2013
    Publication date: March 13, 2014
    Applicant: SELEXYS PHARMACEUTICALS CORPORATION
    Inventors: Rodger P. MCEVER, Richard ALVAREZ, Ziad KAWAR
  • Anti-P-selectin antibodies and methods of using the same to treat inflammatory diseases
    Patent number: 8377440
    Abstract: The invention features antibodies, e.g., chimeric and humanized antibodies, that recognize (i.e., bind) P-selectin. The P-selectin antibodies prevent P-selectin from binding to its cognate receptor. The P-selectin antibodies can be used to treat inflammatory and thrombotic conditions, e.g., sickle cell disease, pain crisis associated with sickle cell disease, deep vein thrombosis, asthma, rheumatoid arthritis, psoriasis, and ischemia reperfusion injury in a patient in need thereof.
    Type: Grant
    Filed: November 30, 2007
    Date of Patent: February 19, 2013
    Assignees: Selexys Pharmaceuticals Corporation, Oklahoma Medical Research Foundation
    Inventors: Rodger P. McEver, Richard Alvarez, Ziad Kawar
  • ANTI-P-SELECTIN ANTIBODIES AND METHODS OF USING THE SAME TO TREAT INFLAMMATORY DISEASES
    Publication number: 20110243926
    Abstract: The invention features antibodies, e.g., chimeric and humanized antibodies, that recognize (i.e., bind) P-selectin. The P-selectin antibodies prevent P-selectin from binding to its cognate receptor. The P-selectin antibodies can be used to treat inflammatory and thrombotic conditions, e.g., sickle cell disease, pain crisis associated with sickle cell disease, deep vein thrombosis, asthma, rheumatoid arthritis, psoriasis, and ischemia reperfusion injury in a patient in need thereof.
    Type: Application
    Filed: November 30, 2007
    Publication date: October 6, 2011
    Applicant: SELEXYS PHARMACEUTICALS CORPORATION
    Inventors: Rodger P. McEver, Richard Alvarez, Ziad Kawar